Literature DB >> 28893805

MELAS syndrome associated with a new mitochondrial tRNA-Val gene mutation (m.1616A>G).

Yuka Toyoshima1, Yuji Tanaka1, Kazuo Satomi1.   

Abstract

We describe the case of a 40-year-old-man with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, with cardiomyopathy and severe heart failure. He had a mitochondrial transfer RNA (tRNA) mutation (m.1616A>G) of the (tRNA-Val) gene, and it was not found in MELAS syndrome ever before. The presence of this newly observed tRNA-Val mutation (m.1616A>G) may induce multiple respiratory chain enzyme deficiencies and contribute to MELAS syndrome symptoms that are associated with mitochondrial DNA (mtDNA) mutations. We report that the pathognomonic symptom in MELAS syndrome caused by this newly observed mtDNA mutation may be rapid progression of cardiomyopathy and severe heart failure. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  muscle disease; neurology

Mesh:

Substances:

Year:  2017        PMID: 28893805      PMCID: PMC5623297          DOI: 10.1136/bcr-2017-220934

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  MELAS associated with mutations in the POLG1 gene.

Authors:  M Deschauer; S Tennant; A Rokicka; L He; T Kraya; D M Turnbull; S Zierz; R W Taylor
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

Review 2.  [The MELAS syndrome and dilated-hypertrophic cardiomyopathy: a case report].

Authors:  M Cristofari; P Bertocchi; M Viganò
Journal:  G Ital Cardiol       Date:  1995-01

3.  MELAS: a nationwide prospective cohort study of 96 patients in Japan.

Authors:  Shuichi Yatsuga; Nataliya Povalko; Junko Nishioka; Koju Katayama; Noriko Kakimoto; Toyojiro Matsuishi; Tatsuyuki Kakuma; Yasutoshi Koga
Journal:  Biochim Biophys Acta       Date:  2011-04-02

4.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

Review 5.  MELAS syndrome.

Authors:  S J Koga; M Hodges; C Markin; P Gorman
Journal:  West J Med       Date:  1995-10

6.  Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease.

Authors:  Giuseppe Limongelli; Maite Tome-Esteban; Charungthai Dejthevaporn; Shamima Rahman; Michael G Hanna; Perry M Elliott
Journal:  Eur J Heart Fail       Date:  2010-02       Impact factor: 15.534

7.  A surviving case of mitochondrial cardiomyopathy diagnosed from the symptoms of multiple organ dysfunction syndrome.

Authors:  Yasuyuki Tsujita; Takeo Kunitomo; Masanori Fujii; Satoshi Furukawa; Hideki Otsuki; Kazunori Fujino; Tetsu Hamamoto; Takahisa Tabata; Kazuhiro Matsumura; Teiji Sasaki; Takao Saotome; Hiromichi Kawai; Tetsuya Matsumoto; Kengo Maeda; Minoru Horie; Yutaka Eguchi
Journal:  Int J Cardiol       Date:  2007-08-08       Impact factor: 4.164

8.  Progressive cardiomyopathy as manifestation of mitochondrial disease.

Authors:  D N Nan; M Fernández-Ayala; J Infante; P Matorras; J González-Macías
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

  8 in total
  3 in total

Review 1.  The Diseased Mitoribosome.

Authors:  Alberto Ferrari; Samuel Del'Olio; Antoni Barrientos
Journal:  FEBS Lett       Date:  2020-12-22       Impact factor: 4.124

Review 2.  Human Mitoribosome Biogenesis and Its Emerging Links to Disease.

Authors:  Maria Isabel G Lopez Sanchez; Annika Krüger; Dmitrii I Shiriaev; Yong Liu; Joanna Rorbach
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 3.  Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.

Authors:  Daniella H Hock; David R L Robinson; David A Stroud
Journal:  Biochem J       Date:  2020-11-13       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.